Search

for
Search:

Glossary Sustained Drug Release

Sustained drug release refers to a method of delivering medication over an extended period, allowing for a gradual release of the active ingredient into the bloodstream. In the context of hair loss treatments, this approach can enhance the effectiveness of topical or systemic therapies by maintaining consistent drug levels, potentially improving outcomes in conditions like androgenetic alopecia. Key distinguishing characteristics include the formulation of the drug, which may involve polymers or other materials that control the rate of release, and the ability to reduce the frequency of dosing, thereby improving patient compliance.

Related Terms

Research

5 / 1000+ results

research Novel tip-loaded dissolving and implantable microneedle array patches for sustained release of finasteride

23 citations , July 2021 in “International Journal of Pharmaceutics”

This study describes the development of microneedle array patches for finasteride that released the drug over 7 to 14 days in vitro, suggesting a potential alternative to oral treatments for long-term management of benign prostatic hyperplasia and androgenic alopecia.

research Dissolving microneedle array patches containing mesoporous silica nanoparticles of different pore sizes as a tunable sustained release platform

7 citations , December 2024 in “International Journal of Pharmaceutics”

In this study, researchers developed a new method for producing dissolving microneedle array patches containing mesoporous silica nanoparticles, successfully confirming nanoparticle deposition and release in both ex vivo and in vivo models.

research Preparation and Properties of PVA/ZIF‐8 Sustained‐Release Fiber Loaded With Minoxidil Sulfate

January 2026 in “Journal of Applied Polymer Science”

In this study, researchers developed a novel composite fiber by incorporating minoxidil sulfate-loaded ZIF-8 nanoparticles into a polyvinyl alcohol matrix, achieving sustained drug release for up to 220 hours, strong mechanical properties, and the capability for cosmetic applications like wigs.

research Dissolving microneedle array patches containing mesoporous silica nanoparticles of different pore sizes as a tunable sustained release platform

September 2023 in “bioRxiv (Cold Spring Harbor Laboratory)”

This study found that dissolving microneedle array patches containing mesoporous silica nanoparticles can deliver antigen-loaded nanoparticles into mice effectively, inducing strong immune responses similar to traditional subcutaneous injection.

research The Increasing Importance of the Hair Follicle Route in Dermal and Transdermal Drug Delivery

9 citations , January 2015 in “Springer eBooks”

This review discusses the enhancement of drug penetration through hair follicles and reports no new clinical results while noting the potential for future research on controlled drug release methods.

View more "sustained drug release" in research →

Community Join

5 / 148 results

community Breezula Phase III 12-Month Data Released by Cosmo Pharma

42 upvotes 5 months ago

Clascoterone 5% topical solution is effective and safe for long-term use in treating male pattern hair loss. Cosmo Pharma aims for EU and US approval, with a potential US release in late 2027 or early 2028.

community People are hyped about PP405 but what about Veradermics phase 2!

in Research/Science 39 upvotes 11 months ago

Veradermics' phase 2 trial of slow-release oral minoxidil shows promising hair regrowth with minimized side effects, gaining significant attention and funding. PP405 is also noted for its potential as a side-effect-free alternative.

community [Theory] Big Bald is deliberately delaying the cure indefinitely

348 upvotes 1 year ago

The conversation humorously suggests that the hair loss industry, referred to as "Big Bald," deliberately delays a cure to profit from ongoing treatments like minoxidil, finasteride, and dutasteride. Participants debate whether a cure would be more profitable than current treatments, with some suggesting that the industry prefers continuous treatments for sustained profit.

community This could be it!!! New treatment increase hair 500%

340 upvotes 9 months ago

Clascoterone (Breezula) shows a potential 500% increase in hair growth, possibly outperforming minoxidil and finasteride. It is in advanced trials, with hopes for FDA approval, but cost and side effects are concerns.

community End of Hair loss ( AGA ) ? Since they produce it in china probably we don’t need to wait other 10 yrs😁

276 upvotes 6 months ago

GT20029 is a new hair loss treatment in Phase 3 trials in China, using PROTAC technology to target androgen receptors, potentially with fewer side effects than finasteride and minoxidil. VDPHL01, a second-generation minoxidil, is also mentioned as potentially more effective.

View more "sustained drug release" in community →

Learn

1 / 801 results

learn Osteopontin

signaling protein that, when suppressed, may grow hair by reducing inflammation and stem cell loss

View more "sustained drug release" in learn →

Clinics

1 / 13 results

Hair Loss Treatments
Dr Joydeep Roy's Skin Clinic, New S.S.Medicos, (near Cachar high school), Malugram/ Drugs Corner, itkhola near Cachar CollegeSilchar, Assam · IN

Experts

— no results

Try a deeper search in experts →